Dow Component E I Du Pont De Nemours & Company (DD) To Go Ex-dividend Tomorrow

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

The Dow Jones Industrial Average ( ^DJI) is trading up 86 points (+0.5%) at 16,669 as of Monday, May 12, 2014, 10:36 a.m. ET. During this time, 61.3 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 393.5 million. The NYSE advances/declines ratio sits at 2,390 issues advancing vs. 510 declining with 150 unchanged.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Tuesday, May 13, 2014 is the ex-dividend date for Dow component E I du Pont de Nemours & Company (NYSE: DD). Owners of shares as of market close today will be eligible for a dividend of 45 cents per share. At a price of $68.16 as of 10:36 a.m. ET, the dividend yield is 2.6% compared to the average Dow component yield of 2.6%.

The average volume for E I du Pont de Nemours & Company has been 3.9 million shares per day over the past 30 days. E I du Pont de Nemours & Company has a market cap of $62.54 billion and is part of the basic materials sector and chemicals industry. Shares are up 4.3% year-to-date as of Friday's close.

E. I. du Pont de Nemours and Company operates as a science and technology based company worldwide. Its Agriculture segment provides corn hybrid, soybean, canola, sunflower, sorghum, inoculants, wheat, and rice seed products under the Pioneer brand; and herbicides, fungicides, and insecticides. The company has a P/E ratio of 21.9, above the average chemicals industry P/E ratio of 21.7.
  • Practice your dividend trading strategies and win cash in our stock game.

TheStreet Ratings rates E I du Pont de Nemours & Company as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share, expanding profit margins and good cash flow from operations. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing